The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma. Issue 125 (April 2020)
- Record Type:
- Journal Article
- Title:
- The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma. Issue 125 (April 2020)
- Main Title:
- The role of Thallium-201 scintigraphy and Tc-99m pentavalent dimercaptosuccinic acid in diagnosis and grading of chondrosarcoma
- Authors:
- Jo, Olivia
Schlicht, Stephen
Slavin, John
Di Bella, Claudia
Pang, Grant
Powell, Gerard
Spelman, Tim
Choong, Peter FM - Abstract:
- Highlights: Thallium scan may differentiate between enchondromas and low-grade chondrosarcomas. Thallium uptake was associated with a higher grade chondrosarcoma. DMSA (V) may be useful in distinguishing between benign and malignant tumours. The combined use of Thallium and DMSA (V) scans increases diagnostic confidence. Abstract: Purpose: Distinguishing between enchondromas and low-grade (grade 1) chondrosarcomas can be challenging. The aim of this study was to investigate the role of Thallium-201 scintigraphy and Technetium-99 m pentavalent dimercaptosuccinic acid (Tc-99 m DMSA (V)) in the diagnosis and grading of chondrosarcomas. Methods: 232 consecutive patients with pathologically proven cartilaginous tumours between the years 2000 and 2018 were evaluated. We included 197 patients (101 males and 96 females; median age 50 years; range 15–86 years) who underwent Thallium-201(n = 193) and/or Tc-99 m DMSA (V) scanning (n = 67). Increased uptake was defined as uptake greater than background. The reference standard was the histopathological assessment based on a grading system (grade 1–3). Data was analysed using multivariate modelling. Results: There were 46 patients with enchondromas and 151 with chondrosarcomas. Of those, 64 (enchondroma n = 21, chondrosarcoma n = 43) underwent both Thallium-201 and Tc-99 m DMSA (V). Thallium-201 uptake had 7.92 times greater odds of grade 1 chondrosarcomas than enchondromas. Thallium-201 uptake was significantly associated with the oddsHighlights: Thallium scan may differentiate between enchondromas and low-grade chondrosarcomas. Thallium uptake was associated with a higher grade chondrosarcoma. DMSA (V) may be useful in distinguishing between benign and malignant tumours. The combined use of Thallium and DMSA (V) scans increases diagnostic confidence. Abstract: Purpose: Distinguishing between enchondromas and low-grade (grade 1) chondrosarcomas can be challenging. The aim of this study was to investigate the role of Thallium-201 scintigraphy and Technetium-99 m pentavalent dimercaptosuccinic acid (Tc-99 m DMSA (V)) in the diagnosis and grading of chondrosarcomas. Methods: 232 consecutive patients with pathologically proven cartilaginous tumours between the years 2000 and 2018 were evaluated. We included 197 patients (101 males and 96 females; median age 50 years; range 15–86 years) who underwent Thallium-201(n = 193) and/or Tc-99 m DMSA (V) scanning (n = 67). Increased uptake was defined as uptake greater than background. The reference standard was the histopathological assessment based on a grading system (grade 1–3). Data was analysed using multivariate modelling. Results: There were 46 patients with enchondromas and 151 with chondrosarcomas. Of those, 64 (enchondroma n = 21, chondrosarcoma n = 43) underwent both Thallium-201 and Tc-99 m DMSA (V). Thallium-201 uptake had 7.92 times greater odds of grade 1 chondrosarcomas than enchondromas. Thallium-201 uptake was significantly associated with the odds of a higher grade chondrosarcoma (grade 2–3). DMSA (V) positivity was associated with 4.75 times the odds of a chondrosarcoma diagnosis over enchondroma (p = 0.024). DMSA (V) uptake revealed no association with chondrosarcoma grading. Conclusion: Low-grade chondrosarcomas continue to pose a diagnostic dilemma. Thallium-201 scans may identify malignancy in benign appearing tumours as well as differentiate between low-grade and high-grade chondrosarcomas in said malignancies. DMSA (V) may be useful in distinguishing between benign and malignant entities as a whole. … (more)
- Is Part Of:
- European journal of radiology. Issue 125(2020)
- Journal:
- European journal of radiology
- Issue:
- Issue 125(2020)
- Issue Display:
- Volume 125, Issue 125 (2020)
- Year:
- 2020
- Volume:
- 125
- Issue:
- 125
- Issue Sort Value:
- 2020-0125-0125-0000
- Page Start:
- Page End:
- Publication Date:
- 2020-04
- Subjects:
- Tc-99m DMSA (V) Technetium-99m pentavalent dimercaptosuccinic acid
Chondrosarcoma -- Cartilaginous tumours -- Thallium-201 -- Pentavalent dimercaptosuccinic acid -- Functional imaging -- Diagnostic imaging
Medical radiology -- Periodicals
Radiology -- Periodicals
Radiologie médicale -- Périodiques
Medical radiology
Periodicals
616.075705 - Journal URLs:
- http://www.sciencedirect.com/science/journal/0720048X ↗
http://www.elsevier.com/homepage/elecserv.htt ↗
http://www.clinicalkey.com/dura/browse/journalIssue/0720048X ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/0720048X ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ejrad.2020.108846 ↗
- Languages:
- English
- ISSNs:
- 0720-048X
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.738050
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 13500.xml